Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s gets CDSCO nod to export 15 drugs to European Union market: Report

Date: 08-08-2016

Dr. Reddy’s Laboratories, Hyderabad-based pharmaceutical company, has reportedly received an approval from the Central Drug Standard Control Organisation (CDSCO) to export drugs for the European Union market. In an order dated August 5, CDSCO gave its nod, which will allow Dr Reddy’s to export 15 active pharmaceutical ingredients (APIs) to the European Union.

These drugs are used to treat hypertension, pneumonia, bacterial infection, cardiovascular diseases and migraine, among others. The order will enable the company to import these substances for a period of three years, ending June 2019.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.